1. Fourtillan, J. B., Granier, J., Saint-Salvi, B., Salmon, J., Surjus, A., Tremblay, D., Vincent du Laurier, M., Beck, S. Pharmacokinetics of Ofloxacin and Theophylline alone and in combination. Infection 14 (1986) S 67–69.
2. Seibert, G., Limbert, M., Klesel, N. Comparison of the anti-bacterialin vitro andin vivo activity of ofloxacin (HOE 280, DL 8280) and nalidixic acid analogues. Eur. J. Clin. Microbiol. 2 (1983) 548–553.
3. Sato, K., Matsuura, Y., Inoue, M., Une, T., Osada, Y., Ogawa, H., Mitsuhashi, S. In vitro andin vivo activity of DL 8280, a new oxazine derivative. Antimicrob. Agents Chemother. 22 (1982) 548–553.
4. Tanimara, H., Kobayashi, N., Saito, T., Sato, T., Takahashi, H., Huang, W. F., Hikasa, Y.: Excretion into bile, tissue level of gallbladder and clinical effects of DL 8280 for biliary tract infections. In:Spitzy, K. H., Karrer, K. (eds.): Proceedings of the 13th International Congress of Chemotherapy, Vienna 1983, part 125, pp 21–26.
5. Suzuki, K., Nagakubo, I., Bandok, T., Aoki, S., Naide, Y.: Clinical evaluation of DL 8280 in bacterial prostatitis. In:Spitzy, K. H., Karrer, K. (eds.): Proceedings of the 13th International Congress of Chemotherapy, Vienna 1983, part 125 pp. 37–40.